NCT03631901 is a Phase 4 clinical trial of oral melatonin in Febrile Seizures, sponsored by Tanta University.

Who is sponsoring NCT03631901?

NCT03631901 is sponsored by Tanta University.

What drugs are being tested in NCT03631901?

Interventions in NCT03631901: oral melatonin, oral diazepam.

What condition does NCT03631901 study?

NCT03631901 studies Febrile Seizures.

Is NCT03631901 still recruiting?

NCT03631901 is currently completed. Last updated 12 September 2019.

Last reviewed 2019-09-12 · How we verify

NCT03631901

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures

Completed Phase 4 Last updated 12 September 2019

What this trial tests

Phase 4 trial testing oral melatonin in Febrile Seizures in 60 participants. Completed in 1 September 2018.

Timeline

1 April 2017

Primary endpoint
1 September 2018

1 September 2018

Quick facts

Lead sponsor	Tanta University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	60
Start date	1 April 2017
Primary completion	1 September 2018
Estimated completion	1 September 2018
Sites	1 location across Egypt

Drugs / interventions tested

oral melatonin
oral diazepam — full drug profile →

Conditions studied

Febrile Seizures — all drugs for Febrile Seizures →

Sponsor

Tanta University

Who can join

Adults 6 Months to 5, any sex, with Febrile Seizures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy of oral melatonin compared to oral diazepam for prevention of recurrent simple febrile seizures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of oral melatonin

Trials testing the same drug.

NCT06724432 — Analgesic and Antioxidant Effects of Melatonin in Pediatric Surgery · NA · completed

Other recruiting trials for Febrile Seizures

Currently open trials in the same condition.

NCT06444126 — The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures · recruiting

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03631901 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 12 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03631901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing